» Articles » PMID: 28982369

Lead Poisoning Among Opium Users in Iran: an Emerging Health Hazard

Abstract

Background: Lead (Pb) poisoning among people using opium has been an increasing problem in Iran. The present study highlights the clinical effects of lead toxicity associated with opium use in Iran, Kerman province.

Methods: Between January 2016 and June 2016, patients with signs and symptoms of Pb poisoning were questioned to assess whether they had a history of opium dependency. In total, 249 patients were enrolled onto this cross-sectional study, all were opium dependent. Para-clinical data including blood lead level (BLL), demographic information, user preferences, and symptoms were obtained.

Results: The patients used either opium (83.9%), refined opium (6.4%) or a combination of both (9.7%) via ingestion (71.9%), smoking (8.4%) or a combination of both (19.7%). The overall median BLL was 80.0 μg/dL [IQR: 51.7-119.0]. The median BLL did not differ significantly between opium and refined opium users. Further, BLL was not significantly affected by the type of substance, route of use, duration of use, or daily quantity consumed. Common symptoms included abdominal pain (86.9%), constipation (75.8%), anorexia (71.5%) and nausea (54.7%). Linear regression analysis showed log of BLL was significantly associated with abdominal pain, myalgia and anorexia.

Conclusions: The study unravelled an increase in opium-related Pb poisoning in the Kerman province. Raised awareness of this emerging Pb source and investigation of its aetiology is recommended. Pb poisoning should be considered among the primary differential diagnosis of opium users with gastrointestinal symptoms.

Citing Articles

Clinico-epidemiological evaluation of pharmaceutical/non-pharmaceutical poisoning in a referral poisoning emergency in the Central part of Iran.

Eizadi-Mood N, Sanjari H, Feizi A, Yazdi R, Dorostkar A, Mahvari R Sci Rep. 2024; 14(1):10493.

PMID: 38714819 PMC: 11076496. DOI: 10.1038/s41598-024-61411-w.


Assessment of Blood Lead Levels in Mothers Addicted to Opium and Their Neonates in Kerman: A Cross-sectional Study.

Sabzevari F, Ahmadipour M, Nezamabadipour N, Jahanara A Addict Health. 2024; 16(1):6-10.

PMID: 38651026 PMC: 11032620. DOI: 10.34172/ahj.2024.1439.


Evaluating the association between opium abuse, blood lead levels, and the complexity of coronary artery disease.

Khameneh Bagheri R, Mousavi S, Mehrad-Majd H, Jamili M, Shad A, Baradaran Rahimi V Physiol Rep. 2024; 12(5):e15975.

PMID: 38480374 PMC: 10937294. DOI: 10.14814/phy2.15975.


Peptic ulcer characteristics in oral opium and non-opium user patients with upper gastrointestinal bleeding.

Masoodi M, Sabzikarian M, Masoodi N, Farhadi S, Rezamand G, Tabaeian S BMC Gastroenterol. 2024; 24(1):42.

PMID: 38254056 PMC: 10802017. DOI: 10.1186/s12876-024-03137-7.


Homogeneous liquid-liquid microextraction based on liquid nitrogen-induced phase separation followed by GFAAS for sensitive extraction and determination of lead in lead-adulterated opium and refined opium.

Ahmadi-Jouibari T, Aghaei A, Sharafi K, Fattahi N RSC Adv. 2022; 10(49):29460-29468.

PMID: 35521102 PMC: 9055943. DOI: 10.1039/d0ra05304j.


References
1.
Hayatbakhsh Abbasi M, Ansari M, Shahesmaeili A, Qaraie A . Lead serum levels in opium-dependent individuals. Addict Health. 2014; 1(2):106-9. PMC: 3905488. View

2.
Karrari P, Mehrpour O, Afshari R, Keyler D . Pattern of illicit drug use in patients referred to addiction treatment centres in Birjand, Eastern Iran. J Pak Med Assoc. 2013; 63(6):711-6. View

3.
Tong S, Von Schirnding Y, Prapamontol T . [Environmental lead exposure: a public health problem with global dimensions]. Servir. 2002; 49(1):35-43. View

4.
Meybodi F, Eslick G, Sasani S, Abdolhoseyni M, Sazegar S, Ebrahimi F . Oral opium: an unusual cause of lead poisoning. Singapore Med J. 2012; 53(6):395-7. View

5.
Karrari P, Mehrpour O, Abdollahi M . A systematic review on status of lead pollution and toxicity in Iran; Guidance for preventive measures. Daru. 2012; 20(1):2. PMC: 3514537. DOI: 10.1186/1560-8115-20-2. View